A new tool in drug development: mapping of compound-protein interaction using forward genetics

Project Information

ACUSLABS

Grant agreement ID: 768524

DOI

10.3030/768524

Project closed

EC signature date 20 June 2017

Start date 1 July 2017

End date 31 December 2018

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

€ 149 563,00

EU contribution

€ 149 563,00

Coordinated by

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
Germany

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Unbiased compound-protein interface mapping and prediction of chemoresistance loci through forward genetics in haploid stem cells

Author(s): Moritz Horn, Virginia Kroef, Kira Allmeroth, Nicole Schuller, Stephan Miethe, Martin Peifer, Josef M. Penninger, Ulrich Elling, Martin S. Denzel
Published in: Oncotarget, Issue 9/11, 2018, ISSN 1949-2553
Publisher: Impact Journals
DOI: 10.18632/oncotarget.24305